Cidara Therapeutics
CDTX
CDTX
56 hedge funds and large institutions have $99.1M invested in Cidara Therapeutics in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
7% less funds holding
Funds holding: 60 → 56 (-4)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
Holders
56
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$10M | |
| 2 | +$6.24M | |
| 3 | +$5.53M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.37M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.21M |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$1.42M | |
| 3 | -$895K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$162K |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
-$156K |